5.1 The Department of Health and the manufacturer have agreed that ipilimumab will be available to the NHS with a patient access scheme which makes ipilimumab available with a discount. The size of the discount is commercial in confidence. It is the responsibility of the manufacturer to communicate details of the discount to the relevant NHS organisations. Any enquiries from NHS organisations about the patient access scheme should be directed to: Bristol-Myers Squibb, telephone number 01244 586250, email firstname.lastname@example.org.
5.2 NICE has developed a costing template to estimate the national and local savings and costs associated with implementation to help organisations put this guidance into practice.